These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-beta type I receptor (ALK5) inhibitors. Ren JX, Li LL, Zou J, Yang L, Yang JL, Yang SY. Eur J Med Chem; 2009 Nov; 44(11):4259-65. PubMed ID: 19640613 [Abstract] [Full Text] [Related]
11. Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors. Vyas VK, Ghate M, Goel A. J Mol Graph Model; 2013 May; 42():17-25. PubMed ID: 23507201 [Abstract] [Full Text] [Related]
12. Tri- and tetrasubstituted imidazoles as p38α mitogen-activated protein kinase inhibitors. Laufer S, Hauser D, Stegmiller T, Bracht C, Ruff K, Schattel V, Albrecht W, Koch P. Bioorg Med Chem Lett; 2010 Nov 15; 20(22):6671-5. PubMed ID: 20934337 [Abstract] [Full Text] [Related]
13. p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies. Gangwal RP, Bhadauriya A, Damre MV, Dhoke GV, Sangamwar AT. Curr Top Med Chem; 2013 Nov 15; 13(9):1015-35. PubMed ID: 23651481 [Abstract] [Full Text] [Related]
16. Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas. Li HF, Lu T, Zhu T, Jiang YJ, Rao SS, Hu LY, Xin BT, Chen YD. Eur J Med Chem; 2009 Mar 15; 44(3):1240-9. PubMed ID: 18947905 [Abstract] [Full Text] [Related]
17. Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors. Das J, Moquin RV, Pitt S, Zhang R, Shen DR, McIntyre KW, Gillooly K, Doweyko AM, Sack JS, Zhang H, Kiefer SE, Kish K, McKinnon M, Barrish JC, Dodd JH, Schieven GL, Leftheris K. Bioorg Med Chem Lett; 2008 Apr 15; 18(8):2652-7. PubMed ID: 18359226 [Abstract] [Full Text] [Related]
18. Structure-based virtual screening approach to the discovery of p38 MAP kinase inhibitors. Choi H, Park HJ, Shin JC, Ko HS, Lee JK, Lee S, Park H, Hong S. Bioorg Med Chem Lett; 2012 Mar 15; 22(6):2195-9. PubMed ID: 22342625 [Abstract] [Full Text] [Related]
19. Design, synthesis, and structure-activity relationships of aminopyridine N-oxides, a novel scaffold for the potent and selective inhibition of p38 mitogen activated protein kinase. Lumeras W, Caturla F, Vidal L, Esteve C, Balagué C, Orellana A, Domínguez M, Roca R, Huerta JM, Godessart N, Vidal B. J Med Chem; 2009 Sep 10; 52(17):5531-45. PubMed ID: 19678708 [Abstract] [Full Text] [Related]
20. Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds. Murali Dhar TG, Wrobleski ST, Lin S, Furch JA, Nirschl DS, Fan Y, Todderud G, Pitt S, Doweyko AM, Sack JS, Mathur A, McKinnon M, Barrish JC, Dodd JH, Schieven GL, Leftheris K. Bioorg Med Chem Lett; 2007 Sep 15; 17(18):5019-24. PubMed ID: 17664068 [Abstract] [Full Text] [Related] Page: [Next] [New Search]